AI Matrix Map home

Vertical + Enterprise · Private company · Growth

Abridge

✓ Verified

Abridge matters because it is one of the clearest enterprise AI companies converting ambient clinical conversation into large-scale healthcare workflow infrastructure.

Pittsburgh, USFounded 2018No public API trackedWeekday review target

Editorial intelligence brief

Editorial focus

Weekday review target

Announced an enterprise-wide agreement with University of Texas REAL Health AI on October 8, 2026, creating a framework for UT System institutions to access its clinician intelligence platform while retaining local implementation decisions.

Focus: Generative AI clinical documentation and healthcare conversation intelligence

Latest funding

$300M

Series E · source-backed

Tracked funding

$300M

Sum of itemized funding events

Latest valuation

Not tracked

No source-backed record

Latest revenue

Not tracked

Growth lifecycle position

Editorially verified updates

What changed

All Abridge updates →
company

Abridge announces UT System agreement

Announced an enterprise-wide agreement with University of Texas REAL Health AI on October 8, 2026, creating a framework for UT System institutions to access its clinician intelligence platform while retaining local implementation decisions.

Abridge · Read source ↗Source published Oct 8, 2026Added to map Oct 16, 2026

External coverage of Abridge

Selected by relevance, date and publisher; grouped by story. External reporting is not independently verified by the map. Article dates are publisher timestamps supplied by the discovery feed; quieter profiles may show coverage up to 90 days old.

Last checked Oct 18, 2026.

No eligible recent coverage found. Verified updates and profile sources remain available above and below.

Source-backed financial history

Funding and financial history

Funding, valuation, revenue, and debt are kept separate so unlike measurements are never presented as one trend.

partial coverage · 1 record

Records

1

Sum of recorded funding

$300M

Coverage

partial

Partial history: earlier or intervening rounds may be missing. The sum covers only the announcements recorded here, not lifetime funding. Announced commitments may be paid over time; this is not a cash balance. Dates show announcements or first public reports, which can follow the investment itself.

#1

Series E · $300M

Running tracked total: $300M

Sources and details for every recorded funding announcement, newest first.

Product surface

Products and model families

Recent models

No standalone model family is structured for this profile.

Products

Clinical documentationRevenue CycleNursing

Open weights

No

API access

No

Review target

Weekday

Market position

Lifecycle and strategic signals

Research

Preview

Growth

Deployment

Growth: Public access & scaling

Focus

Generative AI clinical documentation and healthcare conversation intelligence

Signals

EnterpriseSpeechWorkflow AI

Taxonomy

Workflow AIVertical + Enterprise

Competitive context

NuanceSukiHippocratic AI

Infrastructure & distribution

Where Abridge sits in the AI stack

Model / product operator
01

Model layer

No standalone model family tracked

02

Access layer

Application or managed product

03

Market layer

Vertical + Enterprise

Public product surface

Clinical documentationRevenue CycleNursing

Stack signals

Workflow AIEnterpriseSpeech

This section reflects publicly visible product and access signals. Undisclosed GPU, cloud, training, and data-center contracts are not inferred.

Evidence trail

Sources and corrections

Primary and public sources used to verify the structured company profile.

Submit a correction →

The Staticbreaker

Get the signal behind the week's AI changes.

The Staticbreaker turns launches, category shifts, and market noise into a concise editorial briefing.